Saccharomyces CDK1 phosphorylates Rad53 kinase in metaphase, influencing cellular morphogenesis

Laura Diani1, Claudia Colombelli, Benjamin Tamilselvan Nachimuthu

  • 1Dipartimento di Scienze Biomolecolari e Biotecnologie, Universita' degli Studi di Milano, Via Celoria 26, 20133 Milano, Italy.

Insights

The protein kinase Rad53, crucial for DNA repair checkpoints, is phosphorylated by Clb-CDK1 at Ser774. This modification impacts cellular morphogenesis but not DNA damage or replication roles.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Rad53 is a key protein kinase regulating DNA damage and replication stress checkpoints in budding yeast.
  • Rad53 also plays a role in cellular morphogenesis.
  • Phosphorylation sites on Rad53 include SQ/TQ and SP/TP residues, targeted by PI3K-related kinases and CDKs.

Purpose of the Study:

  • To investigate the role of Clb-CDK1 in phosphorylating Rad53.
  • To determine the impact of Rad53 phosphorylation at Ser774 on its known functions.
  • To explore the connection between Rad53 phosphorylation and cellular morphogenesis.

Main Methods:

  • Mass spectrometry was used to identify phosphorylation sites on Rad53.
  • Site-directed mutagenesis was employed to create a Ser774-to-Asp mutation.
  • Sensitivity to calcofluor was assessed to evaluate cellular morphogenesis defects.

Main Results:

  • Clb-CDK1 phosphorylates Rad53 at Ser774 during metaphase.
  • This phosphorylation event is independent of the spindle assembly checkpoint.
  • Phosphorylation at Ser774 does not affect Rad53's DNA damage or replication checkpoint functions.
  • A Ser774-to-Asp mutation confers calcofluor sensitivity, indicating a role in morphogenesis.

Conclusions:

  • Clb-CDK1-mediated phosphorylation of Rad53 at Ser774 is a novel regulatory mechanism.
  • This specific phosphorylation event links Rad53 to cellular morphogenesis processes.
  • Rad53's role extends beyond DNA checkpoints to include cytoskeletal regulation.

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Separation of Sister Chromatids02:17

Separation of Sister Chromatids

At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...